Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy DOI Open Access

Narin Öztürk,

Dilek Öztürk Civelek, İbrahim Halil Kavaklı

et al.

International Journal of Molecular Sciences, Journal Year: 2017, Volume and Issue: 18(10), P. 2168 - 2168

Published: Oct. 17, 2017

The circadian timing system (CTS) controls various biological functions in mammals including xenobiotic metabolism and detoxification, immune functions, cell cycle events, apoptosis angiogenesis. Although the importance of CTS is well known pharmacology drugs, it less appreciated at clinical level. Genome-wide studies highlighted that majority drug target genes are controlled by CTS. This suggests chronotherapeutic approaches should be taken for many drugs to enhance their effectiveness. Currently successfully applied treatment different types cancers. chronotherapy approach has improved tolerability antitumor efficacy anticancer both experimental animals cancer patients. Thus, chronobiological have been determining most appropriate time administration agents minimize side effects or toxicity efficacy, so as optimize therapeutic ratio. review focuses on underlying mechanisms i.e., chronopharmacokinetics chronopharmacodynamics with molecular aspects, provides an overview some recent advances development chronopharmaceutics.

Language: Английский

Cancer and the Circadian Clock DOI Open Access
Ayesha A. Shafi, Karen E. Knudsen

Cancer Research, Journal Year: 2019, Volume and Issue: 79(15), P. 3806 - 3814

Published: July 12, 2019

The circadian clock is a master regulator of mammalian physiology, regulating daily oscillations crucial biological processes and behaviors. Notably, disruption has recently been identified as an independent risk factor for cancer classified carcinogen. As such, it imperative to discern the underpinning mechanisms by which alters risk. Emergent data, reviewed herein, demonstrate that regulatory functions play critical roles in several hallmarks cancer, including control cell proliferation, death, DNA repair, metabolic alteration. Developing deeper understanding circadian-cancer regulation cross-talk holds promise developing new strategies interception, prevention, management.

Language: Английский

Citations

197

Importance of circadian timing for aging and longevity DOI Creative Commons
Victoria A. Acosta-Rodríguez, Filipa Rijo‐Ferreira, Carla B. Green

et al.

Nature Communications, Journal Year: 2021, Volume and Issue: 12(1)

Published: May 17, 2021

Dietary restriction (DR) decreases body weight, improves health, and extends lifespan. DR can be achieved by controlling how much and/or when food is provided, as well adjusting nutritional composition. Because these factors are often combined during DR, it unclear which necessary for beneficial effects. Several drugs have been utilized that target nutrient-sensing gene pathways, many of change expression throughout the day, suggesting timing drug administration critical. Here, we discuss dietary pharmacological interventions promote a healthy lifespan influencing energy intake circadian rhythms.

Language: Английский

Citations

183

Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes DOI Creative Commons
Dongyin Guan, Ying Xiong,

Patrícia Cristine Borck

et al.

Cell, Journal Year: 2018, Volume and Issue: 174(4), P. 831 - 842.e12

Published: July 26, 2018

Overnutrition disrupts circadian metabolic rhythms by mechanisms that are not well understood. Here, we show diet-induced obesity (DIO) causes massive remodeling of enhancer activity in mouse liver, triggering synchronous high-amplitude both fatty acid (FA) synthesis and oxidation. SREBP expression was rhythmically induced DIO, leading to FA and, surprisingly, oxidation (FAO). DIO similarly caused a rhythm PPARα, which also required for FAO. Provision pharmacological activator PPARα abrogated the requirement FAO (but synthesis), suggesting indirectly controls via production endogenous ligands. The imparted time-of-day-dependent responsiveness lipid-lowering drugs. Thus, acquisition rhythmicity non-core clock components SREBP1 remodels gene transcription response overnutrition enables chronopharmacological approach disorders.

Language: Английский

Citations

180

Metabolic and cardiovascular consequences of shift work: The role of circadian disruption and sleep disturbances DOI
Laura Kervezee, Anastasi Kosmadopoulos, Diane B. Boivin

et al.

European Journal of Neuroscience, Journal Year: 2018, Volume and Issue: 51(1), P. 396 - 412

Published: Oct. 25, 2018

Abstract Shift work, defined as work occurring outside typical daytime working hours, is associated with an increased risk of various non‐communicable diseases, including diabetes and cardiovascular disease. Disruption the internal circadian timing system concomitant sleep disturbances thought to play a critical role in development these health problems. Indeed, controlled laboratory studies have shown that short‐term misalignment restriction independently impair physiological processes, insulin sensitivity, energy expenditure, immune function, blood pressure cardiac modulation by autonomous nervous system. If allowed persist, acute effects may lead cardiometabolic diseases long term. Here, we discuss evidence for contributions disruption metabolic problems shift workers. Improving understanding mechanisms affected disturbance will contribute implementation strategies prevent or mitigate impact work.

Language: Английский

Citations

174

Targeting the CCL2–CCR2 axis for atheroprotection DOI
Marios K. Georgakis, Jürgen Bernhagen, Laura H. Heitman

et al.

European Heart Journal, Journal Year: 2022, Volume and Issue: 43(19), P. 1799 - 1808

Published: Feb. 16, 2022

Decades of research have established atherosclerosis as an inflammatory disease. Only recently though, clinical trials provided proof-of-concept evidence for the efficacy anti-inflammatory strategies with respect to cardiovascular events, thus offering a new paradigm lowering residual vascular risk. Efforts target inflammasome-interleukin-1β-interleukin-6 pathway been highly successful, but inter-individual variations in drug response, lack reduction all-cause mortality, and higher rate infections also highlight need second generation agents targeting atherosclerosis-specific immune mechanisms while minimizing systemic side effects. CC-motif chemokine ligand 2/monocyte-chemoattractant protein-1 (CCL2/MCP-1) orchestrates monocyte trafficking between bone marrow, circulation, atherosclerotic plaques by binding its cognate receptor CCR2. Adding strong body data from experimental models, coherent series recent large-scale genetic observational epidemiological studies along human relevance therapeutic potential CCL2-CCR2 axis atherosclerosis. Here, we summarize pinpointing emerging Furthermore, contextualize previous efforts interfere this pathway, scrutinize approaches vs. targeting, discuss possible pathway-intrinsic opportunities challenges related pharmacological

Language: Английский

Citations

118

Sex-dimorphic and age-dependent organization of 24-hour gene expression rhythms in humans DOI
Lorenzo Figà Talamanca, Cédric Gobet, Félix Naef

et al.

Science, Journal Year: 2023, Volume and Issue: 379(6631), P. 478 - 483

Published: Feb. 2, 2023

The circadian clock modulates human physiology. However, the organization of tissue-specific gene expression rhythms and how these depend on age sex is not defined in humans. We combined data from Genotype-Tissue Expression (GTEx) project with an algorithm that assigns phases to 914 donors, by integrating temporal information multiple tissues each individual, identify messenger RNA (mRNA) 46 tissues. Clock transcripts showed conserved timing relationships tight synchrony across body. mRNA varied breadth, covering global functions, including metabolic pathways systemic responses. structure was sexes groups. overall were highly sex-dimorphic more sustained females. Rhythmic programs generally dampened

Language: Английский

Citations

100

Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle DOI Creative Commons
Meng Qu, Guoxin Zhang, Han Qu

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2023, Volume and Issue: 120(2)

Published: Jan. 3, 2023

Hepatocellular carcinoma (HCC) remains a global health challenge whose incidence is growing worldwide. Previous evidence strongly supported the notion that circadian clock controls physiological homeostasis of liver and plays key role in hepatocarcinogenesis. Despite progress, cellular molecular mechanisms underpinning this HCC-clock crosstalk remain unknown. Addressing knowledge gap, we show here although human HCC cells Hep3B, HepG2, Huh7 displayed variations rhythm profiles, all relied on master transcription factors, BMAL1 CLOCK, for sustained cell growth. Down-regulating Bmal1 or Clock induced apoptosis arrested cycle at G 2 /M phase. Mechanistically, found inhibiting / dysregulation regulators Wee1 p21 which cooperatively contribute to tumor death. knockdown caused downregulation led activation upregulation Collectively, our results suggest CLOCK promote proliferation by controlling levels, thereby preventing arrest. Our findings shed light impact proteins maintaining oncogenesis provide proof-of-principle developing cancer therapy based modulation clock.

Language: Английский

Citations

80

Foundations of circadian medicine DOI Creative Commons
Achim Kramer, Tanja Lange, Claudia Spies

et al.

PLoS Biology, Journal Year: 2022, Volume and Issue: 20(3), P. e3001567 - e3001567

Published: March 24, 2022

The circadian clock is an evolutionarily highly conserved endogenous timing program that structures physiology and behavior according to the time of day. Disruption rhythms associated with many common pathologies. emerging field medicine aims exploit mechanisms clock–disease interaction for clinical diagnosis, treatment, prevention. In this Essay, we outline principle approaches medicine, highlight development in selected areas, point out open questions challenges. Circadian has unambiguous health benefits over standard care but rarely utilized. It biology become integrated part translational research.

Language: Английский

Citations

70

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer DOI Creative Commons

Shi-Yang Li,

Jan A. Hammarlund,

Gang Wu

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2024, Volume and Issue: 121(7)

Published: Feb. 6, 2024

Studies in shift workers and model organisms link circadian disruption to breast cancer. However, molecular rhythms noncancerous cancerous human tissues their clinical relevance are largely unknown. We reconstructed informatically, integrating locally collected, time-stamped biopsies with public datasets. For tissue, inflammatory, epithelial–mesenchymal transition (EMT), estrogen responsiveness pathways show modulation. Among tumors, clock correlation analysis demonstrates subtype-specific changes organization. Luminal A organoids informatic ordering of luminal samples exhibit continued, albeit dampened reprogrammed rhythms. CYCLOPS magnitude, a measure global rhythm strength, varied widely among samples. Cycling EMT pathway genes was markedly increased high-magnitude tumors. Surprisingly, patients tumors had reduced 5-y survival. Correspondingly, 3D cultures invasion following disruption. This study links cancer EMT, metastatic potential, prognosis.

Language: Английский

Citations

21

Universal method for robust detection of circadian state from gene expression DOI Creative Commons
Rosemary Braun, William L. Kath, Marta Iwanaszko

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2018, Volume and Issue: 115(39)

Published: Sept. 10, 2018

Circadian clocks play a key role in regulating vast array of biological processes, with significant implications for human health. Accurate assessment physiological time using transcriptional biomarkers found blood can significantly improve diagnosis circadian disorders and optimize the delivery therapeutic treatments. To be useful, such test must accurate, minimally burdensome to patient, readily generalizable new data. A major obstacle development gene expression biomarker tests is diversity measurement platforms inherent variability data, often resulting predictors that perform well original datasets but cannot universally applied samples collected other settings. Here, we introduce TimeSignature, an algorithm robustly infers from expression. We demonstrate its application data three independent studies distinct microarrays further validate it against set profiled by RNA-sequencing. Our results show TimeSignature more accurate efficient than competing methods, estimating within 2 h majority samples. Importantly, once trained on single study, predictor yield highly differences study population, patient protocol, or assay platform without renormalizing retraining. This feature unique among expression-based addresses challenge generalizable, clinically useful tests.

Language: Английский

Citations

149